Clinical trial
Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)
NCT00393523 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00393523 |
|---|---|
| Title | Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED) |
| Official title | A Study to Assess the Anamnestic Immune Response 4 to 8 Years After a Primary Vaccination Series With HBVAXPRO |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B |
| Intervention type | Biological |
| Interventions | Comparator: Modified Process Hepatitis B Vaccine, Comparator: Comparator: ENGERIX-B |
| Enrollment | 1,478 |
| Start date | Sep 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Oct 27, 2006 |
| Last update posted | Apr 12, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: